Evidence map›Paper›PMID 28389464›Full record

ArticleEMBO reports2017

Chromatin determinants impart camptothecin sensitivity.

Fabio Puddu, Israel Salguero, Mareike Herzog, Nicola J Geisler, Vincenzo Costanzo, Stephen P Jackson

Open access · hybridAbstract read
In one paragraph

Article in EMBO reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Effects of sirtuins on the riboflavin production in Ashbya gossypii.Applied microbiology and biotechnology · 2021
    Article
  4. Article
  5. Article
  6. Sir2 mitigates an intrinsic imbalance in origin licensing efficiency between early- and late-replicating euchromatin.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Fabio PudduThe Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK f.puddu@gurdon.cam.ac.uk s.jackson@gurdon.cam.ac.uk.ORCID 0000-0002-2033-5209
Israel SalgueroThe Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK.
Mareike HerzogThe Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK.
Nicola J GeislerThe Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK.
Vincenzo CostanzoIFOM (Fondazione Istituto FIRC di Oncologia Molecolare), Milan, Italy.
Stephen P JacksonThe Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK f.puddu@gurdon.cam.ac.uk s.jackson@gurdon.cam.ac.uk.ORCID 0000-0001-9317-7937
University of Cambridge · GBIFOM · IT

Funding

Cancer Research UK 11224Cancer Research UK 18796Cancer Research UK C6946/A14492Cancer Research UK C6/A11224Cancer Research UK C6/A18796Wellcome Trust 098051Wellcome Trust 101126/Z/13/ZWellcome Trust WT092096
6 · The paper itself

Abstract

Camptothecin-induced locking of topoisomerase 1 on DNA generates a physical barrier to replication fork progression and creates topological stress. By allowing replisome rotation, absence of the Tof1/Csm3 complex promotes the conversion of impending topological stress to DNA catenation and causes camptothecin hypersensitivity. Through synthetic viability screening, we discovered that histone H4 K16 deacetylation drives the sensitivity of yeast cells to camptothecin and that inactivation of this pathway by mutating H4 K16 or the genes

Indexed as

ChromatinBenzamidesCamptothecinCell Cycle ProteinsDNA-Binding ProteinsDNA DamageDNA, FungalDNA ReplicationDNA, RibosomalDNA Topoisomerases, Type IHumansNaphtholsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSilent Information Regulator Proteins, Saccharomyces cerevisiaeBenzamidesCamptothecinCell Cycle ProteinsChromatinDNA-Binding ProteinsDNA, FungalDNA, RibosomalDNA Topoisomerases, Type INaphtholsSaccharomyces cerevisiae ProteinsSilent Information Regulator Proteins, Saccharomyces cerevisiaeSIR1 protein, S cerevisiaesirtinolTOF1 protein, S cerevisiaeTOP1 protein, humancamptothecinH4‐K16SIR complexsynthetic viabilityTof1

Identifiers

PMID28389464
PMCPMC5452016
OpenAlexW2604114777

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.